Table 3.

Logistic regression analysis results of the effect of unfavorable factors for CR in 190 patients, excluding those with the M3 subtype, treated according to JALSG protocols


Variable

P

Odds ratio

95% CI
NPM1, wild type   <.001   8.434   2.562-27.77  
FAB, other than M2   .008   3.247   1.353-7.813  
Cytogenetic, other than good risk   .039   5.240   1.091-25.16  
NRAS, mutation   .056   2.667   0.978-7.299  
TP53, mutation   .058   6.024   0.941-38.46  
WBC count, more than 100 × 109/L   .090   2.427   0.872-6.757  
FLT3, mutation   .279   1.719   0.645-4.583  
Age, older than 60 y
 
.960
 
2.427
 
0.446-2.340
 

Variable

P

Odds ratio

95% CI
NPM1, wild type   <.001   8.434   2.562-27.77  
FAB, other than M2   .008   3.247   1.353-7.813  
Cytogenetic, other than good risk   .039   5.240   1.091-25.16  
NRAS, mutation   .056   2.667   0.978-7.299  
TP53, mutation   .058   6.024   0.941-38.46  
WBC count, more than 100 × 109/L   .090   2.427   0.872-6.757  
FLT3, mutation   .279   1.719   0.645-4.583  
Age, older than 60 y
 
.960
 
2.427
 
0.446-2.340
 
Close Modal

or Create an Account

Close Modal
Close Modal